Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 451 | 417 | 380 | 3,478 | 599 |
| Gross Profit | 451 | 417 | 380 | 3,478 | 599 |
| Operating Expenses | 9,608 | 6,581 | 7,199 | 5,885 | 6,028 |
| Operating Income | -9,157 | -6,164 | -6,819 | -2,407 | -5,429 |
| Other Income | 76 | 41 | 9 | 5 | 10 |
| Pre-tax Income | -9,081 | -6,123 | -6,810 | -2,402 | -5,419 |
| Net Income Continuous | -9,081 | -6,123 | -6,810 | -2,402 | -5,419 |
| Net Income | $-9,081 | $-6,123 | $-6,810 | $-2,402 | $-5,419 |
| EPS Basic Total Ops | -0.11 | -0.08 | -0.12 | -0.04 | -0.10 |
| EPS Basic Continuous Ops | -0.11 | -0.08 | -0.11 | -0.04 | -0.10 |
| EPS Diluted Total Ops | -0.11 | -0.08 | -0.12 | -0.04 | -0.10 |
| EPS Diluted Continuous Ops | -0.11 | -0.08 | -0.11 | -0.04 | -0.10 |
| EBITDA(a) | $-8,817 | $-6,007 | $-6,770 | $-2,324 | $-5,506 |